| Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of … AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ... The Lancet 393 (10189), 2428-2438, 2019 | 1198 | 2019 |
| Adaptation of HIV-1 to human leukocyte antigen class I Y Kawashima, K Pfafferott, J Frater, P Matthews, R Payne, M Addo, ... Nature 458 (7238), 641-645, 2009 | 559 | 2009 |
| Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis SH Kim, SM Gerver, S Fidler, H Ward Aids 28 (13), 1945-1956, 2014 | 521 | 2014 |
| International AIDS Society global scientific strategy: towards an HIV cure 2016 SG Deeks, SR Lewin, AL Ross, J Ananworanich, M Benkirane, P Cannon, ... Nature medicine 22 (8), 839-850, 2016 | 505 | 2016 |
| British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow … Writing Group, I Williams, D Churchill, J Anderson, M Boffito, M Bower, ... HIV medicine 15, 1-6, 2014 | 421 | 2014 |
| HIV-1 DNA predicts disease progression and post-treatment virological control JP Williams, J Hurst, W Stöhr, N Robinson, H Brown, M Fisher, S Kinloch, ... elife 3, e03821, 2014 | 339 | 2014 |
| Effect of universal testing and treatment on HIV incidence—HPTN 071 (PopART) RJ Hayes, D Donnell, S Floyd, N Mandla, J Bwalya, K Sabapathy, B Yang, ... New England Journal of Medicine 381 (3), 207-218, 2019 | 322 | 2019 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial J Frater, KJ Ewer, A Ogbe, M Pace, S Adele, E Adland, J Alagaratnam, ... The lancet HIV 8 (8), e474-e485, 2021 | 248 | 2021 |
| Uptake of home-based voluntary HIV testing in sub-Saharan Africa: a systematic review and meta-analysis K Sabapathy, R Van den Bergh, S Fidler, R Hayes, N Ford PLoS medicine 9 (12), e1001351, 2012 | 246 | 2012 |
| HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and … R Hayes, H Ayles, N Beyers, K Sabapathy, S Floyd, K Shanaube, P Bock, ... Trials 15, 1-17, 2014 | 231 | 2014 |
| Reductions in HIV transmission risk behaviour following diagnosis of primary HIV infection: a cohort of high‐risk men who have sex with men J Fox, PJ White, N Macdonald, J Weber, M McClure, S Fidler, H Ward HIV medicine 10 (7), 432-438, 2009 | 223 | 2009 |
| Immunological biomarkers predict HIV-1 viral rebound after treatment interruption J Hurst, M Hoffmann, M Pace, JP Williams, J Thornhill, E Hamlyn, ... Nature communications 6 (1), 8495, 2015 | 199 | 2015 |
| Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans KB Yates, P Tonnerre, GE Martin, U Gerdemann, R Al Abosy, ... Nature immunology 22 (8), 1020-1029, 2021 | 184 | 2021 |
| Exhaustion of activated CD8 T cells predicts disease progression in primary HIV-1 infection M Hoffmann, N Pantazis, GE Martin, S Hickling, J Hurst, J Meyerowitz, ... PLoS pathogens 12 (7), e1005661, 2016 | 179 | 2016 |
| Sexual transmission of HIV-1 J Fox, S Fidler Antiviral research 85 (1), 276-285, 2010 | 166 | 2010 |
| A systematic review of definitions of extreme phenotypes of HIV control and progression D Gurdasani, L Iles, DG Dillon, EH Young, AD Olson, V Naranbhai, ... Aids 28 (2), 149-162, 2014 | 140 | 2014 |
| Clinical and public health implications of acute and early HIV detection and treatment: a scoping review SE Rutstein, J Ananworanich, S Fidler, C Johnson, EJ Sanders, O Sued, ... Journal of the International AIDS Society 20 (1), 21579, 2017 | 138 | 2017 |
| Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER … S Fidler, W Stöhr, M Pace, L Dorrell, A Lever, S Pett, S Kinloch-de Loes, ... The Lancet 395 (10227), 888-898, 2020 | 135 | 2020 |
| Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial KM Pollock, HM Cheeseman, AJ Szubert, V Libri, M Boffito, D Owen, ... EClinicalMedicine 44, 2022 | 126 | 2022 |
| What do the Universal Test and Treat trials tell us about the path to HIV epidemic control? D Havlir, S Lockman, H Ayles, J Larmarange, G Chamie, T Gaolathe, ... Journal of the International AIDS Society 23 (2), e25455, 2020 | 126 | 2020 |
